TOP STORY

NECC files for bankruptcy under Chapter 11

The New England Compounding Pharmacy, Inc., which does business as the New England Compounding Center (NECC), filed for bankruptcy protection under Chapter 11 of the Bankruptcy code on December 21 in the U.S. Bankruptcy Court for the District of Massachusetts Eastern Division. » More

Continuing Education

New CPE Series: December activity available now

Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

TODAY'S HEADLINES

Spinal infections from NECC disaster persist

Patients who received spinal or paraspinal injection with contaminated methylprednisolone from the New England Compounding Center (NECC) and have new or worsening symptoms at or near the injection site may have an unrecognized, localized infection there, according to a CDC Health Alert Network (HAN) message issued Dec. 20. » More

Industry-sponsored studies report favorable findings

Industry-sponsored studies are more likely to report favorable findings on the sponsor's drug or device, according to a recent literature review. » More

Tamiflu available for kids 2 weeks and older

Oseltamivir (Tamiflu) can now be used to treat children who are 2 weeks of age and older, according to an FDA press release. » More

TAKE OUR SURVEY

Are you counseling more oncology patients to help with their medication regimens?

- Yes
- No

Click Here to let us know.

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out too

• Letters from readers

• Dabigatran results similar to warfarin

• Analgesics linked to hearing loss in women

• The future is now

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health may fall short despite increased pharmacy workload

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events